Microgen PLC
9 August 2000
ACQUISITION OF TELESMART DEVELOPMENTS LTD
Microgen plc ('Microgen') announces that it has acquired
Telesmart Developments Ltd ('Telesmart'), one of the UK's
leading providers of payment software for BACS processing. This
acquisition provides a strategic enhancement to Microgen's
business-to-business ('B2B') e-billing service where the
preferred e-payment methods in the UK are anticipated to utilise
the BACS system for the foreseeable future.
Telesmart, based in Finchley, was established in 1982 and has a
strong customer base and reputation in payment systems and
services. For the year ended 31 March 1999, the latest period
for which audited accounts are available, Telesmart reported
revenue of £2.05 million and an operating loss of £107,000. Over
the past 15 months, Telesmart has increased investment in new
product development which has resulted in several new products
and services, including : 'BACWAY Vite' a new core product
upgrade providing increased flexibility to incorporate ongoing
BACS changes; direct debit management software designed for
organisations with high volume direct debit payment collections;
and 'BACWAYnet' which enables NHS health authorities and trusts
to make BACS payments using an application service provider
('ASP') model. These investments have increased the operating
losses during this period and the current Telesmart projections
indicate continuing modest losses through the current year until
the new products realise the projected revenue growth.
The total consideration for Telesmart is up to £2.35 million
comprising up to £1.65 million payable in cash and the issue of
approximately 220,000 new Microgen shares. The consideration
includes a deferred payment of £150,000 subject to Telesmart's
operating performance to December 2001. Microgen will also
assume Telesmart's existing indebtedness of approximately
£400,000. Microgen estimates that the acquisition will give rise
to goodwill of up to £4 million which will be capitalised and
written off over 20 years.
Application will be made to the London Stock Exchange for the
new Microgen shares to be admitted to the Daily Official List of
the London Stock Exchange. Dealings in the new Microgen shares
are expected to commence on 14 August 2000.
Commenting on the acquisition, Martyn Ratcliffe, Executive
Chairman of Microgen, said :
'Through the acquisition of Telesmart, Microgen can now provide
an integrated e-billing and e-payment solution designed to
satisfy the requirements of the UK business-to-business sector.
This is a strategically significant acquisition in the
development of our e-business services.'
Further information can be obtained at :
www.microgen.co.uk
www.telesmart.co.uk
For further information, please contact :
Martyn Ratcliffe, Executive Chairman, Microgen plc
Mike Phillips, Group Finance Director, Microgen plc
Tel 01753-847123
Steve Liebmann, Buchanan Communications
Tel 020-7466-5000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.